Figure 2.
Figure 2. Change in phenotype of iDCs following viral transduction. Following transduction of iDCs with Ad0 (third column; MOI 500), AdGFP (fourth column; MOI 500), HIV-GFP (fifth column; MOI 500), or EIAV-GFP (sixth column; MOI 500), the phenotype of the cells was analyzed using 2-color flow cytometry for the expression of (e)GFP (x axis) and the surface marker indicated (y axis). As a control, untransfected cells were either unstimulated (iDCs, first column) or activated with 20 ng/mL TNF-α, 20 ng/mL IL-1β, 20 ng/mL LPS, and 10 ng/mL PGE2 for 48 hours (mDCs, second column). The results shown are representative of 3 experiments. The percentage of cells in each quadrant of the flow cytometry profiles is shown in the diagram beneath each profile.

Change in phenotype of iDCs following viral transduction. Following transduction of iDCs with Ad0 (third column; MOI 500), AdGFP (fourth column; MOI 500), HIV-GFP (fifth column; MOI 500), or EIAV-GFP (sixth column; MOI 500), the phenotype of the cells was analyzed using 2-color flow cytometry for the expression of (e)GFP (x axis) and the surface marker indicated (y axis). As a control, untransfected cells were either unstimulated (iDCs, first column) or activated with 20 ng/mL TNF-α, 20 ng/mL IL-1β, 20 ng/mL LPS, and 10 ng/mL PGE2 for 48 hours (mDCs, second column). The results shown are representative of 3 experiments. The percentage of cells in each quadrant of the flow cytometry profiles is shown in the diagram beneath each profile.

Close Modal

or Create an Account

Close Modal
Close Modal